National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 7167 [2012-3153]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 28 / Friday, February 10, 2012 / Notices
requirements of the applicable statutes
and regulations.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments regarding this document. It is
only necessary to send one set of
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
III. Electronic Access
Persons with access to the Internet
may obtain the document at either
https://www.fda.gov/Drugs/Guidance
ComplianceRegulatoryInformation/
Guidances/default.htm, https://www.fda.
gov/BiologicsBloodVaccines/Guidance
ComplianceRegulatoryInformation/
default.htm or https://
www.regulations.gov.
Dated: February 6, 2012.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2012–3096 Filed 2–9–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
srobinson on DSK4SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel Multi-Center Study
of Tamsulosin for Ureteral Stones in the
Emergency Department.
Date: March 26, 2012.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
VerDate Mar<15>2010
21:29 Feb 09, 2012
Jkt 226001
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 747, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Collaborative
Interdisciplinary Team Science in NIDDK
Research Areas (R24)—Barrett’s Oesophagus
and IBD.
Date: March 30, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; LRP Reviews.
Date: March 30, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: D.G. Patel, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 756, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: February 6, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–3153 Filed 2–9–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Global Rare Diseases Patient Registry
and Data Repository (GRDR) Notice
and Request for Information (RFI)
The Office of Rare Diseases
Research (ORDR), an organizational
component of the National Center for
Advancing Translational Sciences
(NCATS), National Institutes of Health
SUMMARY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
7167
(NIH), is inviting patient organizations
without a patient registry and those
with established patient registries to be
considered for participation in a twoyear pilot project to establish the Global
Rare Diseases Patient Registry and Data
Repository (GRDR), and to submit
background information about their
organization for consideration by the
project’s selection committee. More
information may be found at https://
rarediseases.info.nih.gov/GRDR.
The goal of the GRDR is to enable data
analysis within and across many rare
diseases and to facilitate clinical trials
and other studies. An interface will be
developed to accept de-identified
patient data from existing patient
registries to promote data sharing.
The GRDR will serve rare disease
patients and their advocacy groups
seeking help and information. It will
also serve investigators conducting
research, clinicians treating patients,
epidemiologists analyzing disease data,
and investigators seeking patients for
new clinical trials and initiating natural
history studies.
A researcher portal will allow
authorized researchers to gain access to
de-identified patient data to identify
potential study candidates and to learn
about the natural history of disease.
Because the GRDR will contain only deidentified data, investigators will recruit
prospective participants through the
patient organizations. Direct contact
with the prospective participants would
occur only after the patient has granted
permission.
In order to aggregate data from
different registries to facilitate pandisease analysis, data must be captured
and collected in a standardized manner.
Use of Common Data Elements (CDEs)
facilitates the standardization of data
collection and allows for harmonization,
sharing, and exchange of information
across registries. ORDR has developed a
set of minimal CDEs that have been
accepted and adopted by numerous
national and international patient
advocacy groups and professional
organizations globally. To develop organ
systems and disease specific CDEs,
ORDR is coordinating and collaborating
with the various NIH components,
patient advocacy groups, and
professional organizations that already
have developed similar CDEs or are in
the process of developing them.
The purpose of this pilot program is
to test the different functionalities of the
GRDR. A total of 24 organizations will
be selected. Twelve organizations with
established registries and 12
organizations that have no registry will
be chosen to participate.
E:\FR\FM\10FEN1.SGM
10FEN1
]]>Agencies
[Federal Register Volume 77, Number 28 (Friday, February 10, 2012)]
[Notices]
[Page 7167]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-3153]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel Multi-Center Study of
Tamsulosin for Ureteral Stones in the Emergency Department.
Date: March 26, 2012.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Paul A. Rushing, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 747, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-8895, rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Collaborative
Interdisciplinary Team Science in NIDDK Research Areas (R24)--
Barrett's Oesophagus and IBD.
Date: March 30, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Najma Begum, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 749,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; LRP Reviews.
Date: March 30, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: D.G. Patel, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 756,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7682,
pateldg@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: February 6, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-3153 Filed 2-9-12; 8:45 am]
BILLING CODE 4140-01-P
